[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Influenza A Virus, H5N1 Subtype Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

October 2019 | 130 pages | ID: I5BE7E4D016DEN
VPAResearch

US$ 1,699.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Influenza A Virus, H5N1 Subtype Infections Drug pipeline report- 2020 is an annual R&D review of Influenza A Virus, H5N1 Subtype Infections pipeline candidates. The report presents the current status of all major Influenza A Virus, H5N1 Subtype Infections therapeutic compounds. Detailed insights into Influenza A Virus, H5N1 Subtype Infections pipeline development, current status, companies, drug profiles and Influenza A Virus, H5N1 Subtype Infections preclinical and clinical trials are included.

2020 Influenza A Virus, H5N1 Subtype Infections Pipeline Market Insights
Influenza A Virus, H5N1 Subtype Infections disease overview, 2020 pipeline review, insights into leading companies, dominant mechanism of action, majority of administration route of Influenza A Virus, H5N1 Subtype Infections therapies, pipeline by phase and others are included.

Influenza A Virus, H5N1 Subtype Infections pipeline Drug profiles-
Active and inactive drug profiles covering information including drug name/synonym, sponsor/collaborators/Developer/originator, drug mechanism, route of administration, orphan drug status, NME, phase, development status, and others are included.

Influenza A Virus, H5N1 Subtype Infections Therapeutic Drug candidates
Both active and inactive Influenza A Virus, H5N1 Subtype Infections pipeline drug candidates are included in the report

Influenza A Virus, H5N1 Subtype Infections Clinical Trials and preclinical Studies
Influenza A Virus, H5N1 Subtype Infections In-vitro and In-vivo studies, discovery stage and pre-clinical stage trial details, Clinical trial titles, duration, location, phase, sponsors, and other details are provided.

Influenza A Virus, H5N1 Subtype Infections pipeline market developments
Influenza A Virus, H5N1 Subtype Infections Pipeline market news and deals including mergers, acquisitions, approvals, collaborations, trial initiations, results, investments, licensing opportunities and others are provided.

Influenza A Virus, H5N1 Subtype Infections pipeline companies in active development
The report analyzes Influenza A Virus, H5N1 Subtype Infections pipeline of the below companies-

Abivax SA, Abzyme Therapeutics LLC, Akshaya Bio Inc, Altimmune Inc, Aphios Corp, AusBio Ltd, BiondVax Pharmaceuticals Ltd, CEL-SCI Corp, Chicago Biosolutions Inc, CHO Pharma Inc, Cocrystal Pharma Inc, Curevac AG, Declion Pharmaceuticals Inc, Fides Pharma SPA, FluGen Inc, Gamma Vaccines Pty Ltd, Gamma Vaccines Pty Ltd, Greffex Inc, Hemispherx Biopharma Inc, Inovio Pharmaceuticals Inc, Kineta Inc, Medicago Inc, Medigen Inc, NanoViricides Inc, OPKO Health Inc, PeptiDream Inc, Seqirus Ltd, Shionogi & Co Ltd, TechnoVax Inc, Tria Bioscience Corp, Vacthera BioTech GmbH, Vaxart Inc, Vaxine Pty Ltd, Vertex Pharmaceuticals , Virvio Inc

Report Coverage

What to look out for in 2020
Drugs moving from early stage to mid-to-late stages and drugs to look after in 2020 are included

Pipeline Snapshot
Pipeline candidate count - Drug by phase, mechanism of action, route of administration, designation and others

Companies
35 Companies investing in Influenza A Virus, H5N1 Subtype Infections pipeline from discovery stage to pre-registration phase are included

Drug profiles
Over 10 details of each Influenza A Virus, H5N1 Subtype Infections pipeline candidate are included

Company Profiles
Business overview and contact details of all companies operating in the industry are provided

Market Developments
News, Developments and other recent industry developments are included
1. INFLUENZA A VIRUS, H5N1 SUBTYPE INFECTIONS PIPELINE MARKET INSIGHTS, 2020

1.1 Influenza A Virus, H5N1 Subtype Infections Disease Overview
1.2 Influenza A Virus, H5N1 Subtype Infections Drug Pipeline Snapshot, 2020
  1.2.1 Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs by Phase
  1.2.2 Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs by Company
  1.2.3 Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs by Mechanism of Action
  1.2.4 Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs by Route of Administration

2. INFLUENZA A VIRUS, H5N1 SUBTYPE INFECTIONS COMPANY WISE PIPELINE DETAILS

Abivax SA Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Abzyme Therapeutics LLC Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Akshaya Bio Inc Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Altimmune Inc Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Aphios Corp Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
AusBio Ltd Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
BiondVax Pharmaceuticals Ltd Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
CEL-SCI Corp Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Chicago Biosolutions Inc Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
CHO Pharma Inc Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Cocrystal Pharma Inc Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Curevac AG Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Declion Pharmaceuticals Inc Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Fides Pharma SPA Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
FluGen Inc Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Gamma Vaccines Pty Ltd Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Gamma Vaccines Pty Ltd Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Greffex Inc Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Hemispherx Biopharma Inc Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Inovio Pharmaceuticals Inc Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Kineta Inc Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Medicago Inc Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Medigen Inc Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
NanoViricides Inc Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
OPKO Health Inc Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
PeptiDream Inc Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Seqirus Ltd Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Shionogi & Co Ltd Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
TechnoVax Inc Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Tria Bioscience Corp Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Vacthera BioTech GmbH Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Vaxart Inc Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Vaxine Pty Ltd Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Vertex Pharmaceuticals Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Virvio Inc Influenza A Virus, H5N1 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details

3. INFLUENZA A VIRUS, H5N1 SUBTYPE INFECTIONS DRUG PIPELINE PROFILES

3.1 Discovery and Preclinical Drug Profiles
3.2 Phase 1 Drug Profiles
3.3 Phase 2 Drug Profiles
3.4 Phase 3 Drug Profiles

4. INFLUENZA A VIRUS, H5N1 SUBTYPE INFECTIONS PIPELINE NEWS AND DEVELOPMENTS

5. APPENDIX

5.1 Primary and Secondary Research Methodology
5.2 Publisher Expertize
5.3 Contacts


More Publications